Earnings Scheduled For February 28, 2022
Companies Reporting Before The Bell
• Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter.
Arcturus Therapeutics’ COVID-19 Booster Clinical Trial Show Encouraging Neutralizing Antibody Responses
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) has
Arcturus Therapeutics Updates Data From ARCT-154 And ARCT-165 Booster Clinical Trial Demonstrating Robust Neutralizing Antibody Responses To SARS-CoV-2 And Several Variants
Arcturus Therapeutics Updates Data from ARCT-154 and ARCT-165 Booster Clinical Trial Demonstrating Robust Neutralizing Antibody Responses to SARS-CoV-2 and Several Variants
Full cohort data from the ARCT-154 (5 mcg) arm
58 Biggest Movers From Yesterday
Gainers
Adagio Therapeutics, Inc. (NASDAQ: ADGI) shares jumped 123.3% to settle at $14.18 on Thursday after traders circulated rumors of a reiterated Buy rating and $46 price target from Jefferies.
Arcturus Shares Shoot Higher After Additional Data From COVID-19 Vaccine Programs
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) announced
Arcturus Therapeutics Reports New Data, Provides Additional Updates From ARCT-154 And ARCT-165 Clinical Trials; Co To Evaluate Sera From Vaccinated Participants For Activity Against Omicron Variant
Arcturus Therapeutics Holdings Inc. ((the "Company", "Arcturus", NASDAQ:ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and